BenzingaThu, 18 Jun 2026 19:29:40 GMTTG Therapeutics Stock Rises Thursday: What's Driving The Gains?TGTX-0.80%
Investors Business DailyWed, 17 Jun 2026 12:00:03 GMTTG Therapeutics Stock Is On A Hot Streak: Why It's Up 70% And ClimbingTGTX-0.80%
Zacks Investment ResearchThu, 11 Jun 2026 10:16:07 GMTTG Therapeutics (TGTX) Soars 7.5%: Is Further Upside Left in the Stock?TGTX-0.80%
Zacks Investment ResearchWed, 10 Jun 2026 14:21:05 GMTTGTX Rises on Positive Phase I Data for Subcutaneous Briumvi in MGTGTX-0.80%
Seeking AlphaTue, 09 Jun 2026 21:12:13 GMTTG Therapeutics, Inc. (TGTX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptTGTX-0.80%
Zacks Investment ResearchFri, 05 Jun 2026 16:35:33 GMTWhy Is TG Therapeutics (TGTX) Down 5.7% Since Last Earnings Report?TGTX-0.80%
Zacks Investment ResearchThu, 04 Jun 2026 16:01:16 GMTTGTX Stock Up on Positive Phase I Data for Subcutaneous BriumviTGTX-0.80%
Seeking AlphaThu, 04 Jun 2026 13:00:00 GMTTG Therapeutics: Phase 1 Results Of Subcutaneous Briumvi Are A De-Risking EventTGTX-0.80%
Seeking AlphaThu, 28 May 2026 17:35:11 GMTTG Therapeutics: 'Strong Buy' Amid BRIUMVI Expansion Win And Boosted 2026 OutlookTGTX-0.80%
Zacks Investment ResearchThu, 28 May 2026 15:35:19 GMTTGTX's Single-Dose Briumvi Hits Bioequivalence Goal in MS StudyTGTX-0.80%
Zacks Investment ResearchWed, 20 May 2026 15:56:28 GMTTGTX Stock Rises 29% in 3 Months: Here's What You Should KnowTGTX-0.80%
Zacks Investment ResearchThu, 07 May 2026 17:11:18 GMTTGTX Q1 Earnings Miss, Sales Rise Y/Y, Stock Up on Raised 2026 ViewTGTX-0.80%
Seeking AlphaWed, 06 May 2026 17:11:20 GMTTG Therapeutics, Inc. (TGTX) Q1 2026 Earnings Call TranscriptTGTX-0.80%
Zacks Investment ResearchWed, 06 May 2026 13:25:17 GMTTG Therapeutics (TGTX) Q1 Earnings Lag EstimatesTGTX-0.80%
Zacks Investment ResearchTue, 28 Apr 2026 15:08:34 GMTFortrea Holdings Inc. (FTRE) Reports Next Week: Wall Street Expects Earnings GrowthTGTX-0.80%
Seeking AlphaSun, 19 Apr 2026 02:32:28 GMTTG Therapeutics: Flawless Execution And $500 Million Non-Dilutive Capital Bolster OutlookTGTX-0.80%
Zacks Investment ResearchThu, 16 Apr 2026 14:41:53 GMTTGTX Completes Enrollment in Phase III Study on Subcutaneous BriumviTGTX-0.80%
